Ester Verdaguer
Av. De Joan XXIII, 27-31
Barcelona, CT 08028, Spain
Barcelona, CT 08028, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Epigallocatechin-3-gallate attenuates colistin-induced neuro and nephrotoxicity by preserving mitochondrial function and reducing oxidative stress.
Journal: Biochemical pharmacology
Published: February 24, 2026
Natural senotherapeutics in respiratory health: Addressing cellular senescence, inflammaging, and immunosenescence in the aging lung.
Journal: European journal of pharmacology
Published: October 27, 2025
Targeting the liver-brain axis: Licochalcone A as a therapeutic agent against HFD-induced neurodegeneration.
Journal: Biochemical pharmacology
Published: October 24, 2025
Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.
Journal: GeroScience
Published: September 08, 2025
Colistin treatment causes neuronal loss and cognitive impairment via ros accumulation and neuronal plasticity alterations.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 12, 2024
Licochalcone A prevents cognitive decline in a lipopolysaccharide-induced neuroinflammation mice model.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 31, 2024
From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 15, 2024
JNK signaling and its impact on neural cell maturation and differentiation.
Journal: Life sciences
Published: March 13, 2024
A mammalian-specific Alex3/Gαq protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival.
Journal: Science signaling
Published: February 06, 2024
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.
Journal: International journal of molecular sciences
Published: July 25, 2023
A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer's disease exacerbated with high fat diet.
Journal: Cell & bioscience
Published: December 29, 2022
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 18, 2022
Last Updated: 09/26/2026